The brightest minds in the CDMO industry.

From early development through to commercial manufacturing.


Recipharm’s proprietary molecule Erdosteine has been positively tested as part of COVID-19 treatment

Update on operational impact of COVID-19

We proudly introduce a new addition to the Recipharm family

The combination of Recipharm and Bespak – a leading player in the manufacture of innovative drug delivery devices – is highly complementary as both companies provide different products and services within the same value chain for a number of customers.

Celebrating 25 years

Recipharm has had an incredible journey since it was formed in 1995, and is now a leading global player in the CDMO industry. This year we celebrate our successful journey over 25 years. 

Founders Thomas Eldered and Lars Backsell:

"Recipharm has not been a two man-show, as there are a lot of people that have contributed over the years, and we’ve been fortunate enough to recruit and retain excellent people."


Whether you’re a large or small pharmaceutical company, our talented team can develop and transform your promising molecule into a product. We’ve supported many clients over the years, and you can be next.

Torkel Gren - General Manager

“Recipharm takes responsibility for the full phase I programme, from formulation to clinical trial implementation with patients.”


With production facilities across the world covering a range of product types and dosage forms, you can count on our manufacturing expertise to reliably deliver your product on time, every time. Shall we get started?

Ann Flodin - General Manager

"We are focused on managing complexity for our customers, this means providing a full service offering to simplify the supply chain."


Proud to become a top five global CDMO

2019 Annual Report

Contact us

Your CDMO partner

Developing pharmaceuticals can be a tricky business, so let us help.